7
May
2024

ARL Bio Pharma

Exhibitor at CPHI North America 2024 stand 719
About Us

ARL Bio Pharma is a contract laboratory that provides analytical and microbiological testing to pharmaceutical companies and research scientists. Our laboratory is headquartered in Oklahoma City, Oklahoma, and serves over 3,000 clients nationwide. Since 1998, ARL has supported the industry-wide commitment to deliver high-quality therapeutic drug products by providing guidance and test services for all phases of the product lifecycle following USP, FDA, and ICH guidelines.

Whether you are an innovator or pharmaceutical manufacturer, we provide the testing needed to get your protein t...

  • US
  • 2019
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Contract Service
Contact info
  • 840 Research Parkway Suite 546, Oklahoma City, OK, United States
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 719

Products Featured at CPHI North America 2024

  • Biological Activity

    Product Biological Activity

    This test provides a direct measure of the effectiveness of the active ingredient.
  • Chinese Hamster Ovary Host Cell Protein Testing

    Product Chinese Hamster Ovary Host Cell Protein Testing

    ELISA methods are used to test for the presence of residual host cell proteins left in a drug or therapeutic protein following purification.
  • Compatibility Studies

    Product Compatibility Studies

    Also known as y-site studies, compatibility testing is performed to ensure that the mixing of two different formulations does not impact the physical or chemical properties of the drugs.
  • Dissolution Testing

    Product Dissolution Testing

    Quality tests to ensure proper performance of the formulation, generally solid oral dose forms such as tablets and capsules.
  • E. Coli Host Cell Proteins

    Product E. Coli Host Cell Proteins

    ELISA methods are used to test for the presence of residual host cell proteins left in a drug or therapeutic protein following purification.